IA
ZBIO icon

IFS Advisors’s Zenas BioPharma ZBIO Stock Holding History

IFS Advisors’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.02K Buy
+75
New +$2.31K ﹤0.01% 410

Other funds holding ZBIO

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

IFS Advisors's ZBIO Position: Q3 2026 in Review

IFS Advisors opened a new position in Zenas BioPharma (ZBIO) in Q3 2026: 75 shares worth $2.02K. The stake represents ﹤0.01% of the portfolio and ranks #410 among its holdings.

6 funds tracked by Wall St. Rank hold ZBIO as of Q3 2026.

  • IFS Advisors held 75 shares of Zenas BioPharma worth $2.02K as of Q3 2026.
  • Zenas BioPharma was a new IFS Advisors position in Q3 2026.
  • Zenas BioPharma made up ﹤0.01% of IFS Advisors's portfolio in Q3 2026, its #410 holding.
  • 6 funds tracked by Wall St. Rank held Zenas BioPharma as of Q3 2026.

Based on IFS Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.